サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390611

ホルモン避妊薬市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ホルモン避妊薬市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のホルモン避妊薬市場規模は2022年に179億米ドルに達しました。今後、IMARC Groupは、2028年には229億米ドルに達し、2022～2028年の成長率（CAGR）は4.19%になると予測しています。

ホルモン避妊薬薬は、プロゲスチン、またはエストロゲンとプロゲステロンホルモンの配合剤です。これらは内分泌系に作用して排卵と受精を阻止します。その結果、望まない妊娠を防ぐために使用され、また、生理痛を和らげ、生理が軽くなることが多いことでも知られています。ホルモン避妊薬は最も効果的な方法のひとつと考えられており、膣性交の前後に服用することができます。避妊用ピル、膣リング、避妊用皮膚パッチ、ホルモン放出避妊コイルなどがあります。また、ホルモン避妊薬は子宮内膜に影響を与え、受精卵が着床しにくくなります。

ホルモン避妊薬市場の動向：

世界のホルモン避妊薬市場は、主に家族計画に関する大衆の意識の高まりによって牽引されています。これにより、特に若いカップルの間で、意図しない妊娠を防ぐ必要性が高まっています。さらに、10代の妊娠に関連する健康問題の大幅な増加が、簡単に入手できる避妊薬の使用を促進しています。各国の政府も、手頃な価格で質の高いヘルスケア・サービスを推進することで、こうした製品へのアクセスを支援・改善するさまざまなイニシアチブを採用しています。このほか、ヘルスケア業界の進歩により、ホルモンパッチ、インプラント、子宮内避妊器具、薬剤と器具の組み合わせ製品などの革新的な製品が製造されています。これらのデバイスは副作用が少なく、妊娠を予防する効率が向上しており、市場の成長に好影響を与えています。

本レポートで扱う主な質問

  • 世界のホルモン避妊薬市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が世界のホルモン避妊薬市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • ホルモン別の市場内訳は？
  • 年齢層別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界のホルモン避妊薬市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のホルモン避妊薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 経口避妊薬
    • 市場動向
    • 市場予測
  • 子宮内避妊器具（IUD）
    • 市場動向
    • 市場予測
  • 注射用避妊具
    • 市場動向
    • 市場予測
  • 膣リング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：ホルモン別

  • 黄体ホルモン単独避妊薬
    • 市場動向
    • 市場予測
  • 複合ホルモン避妊薬
    • 市場動向
    • 市場予測

第8章 市場内訳：年齢層別

  • 15-24歳
    • 市場動向
    • 市場予測
  • 25-34歳
    • 市場動向
    • 市場予測
  • 35-44歳
    • 市場動向
    • 市場予測
  • 44歳以上
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Afaxys Inc.
    • Agile Therapeutics Inc.
    • Allergan Inc.（AbbVie Inc.）
    • Bayer AG
    • Cipla Limited
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Piramal Group
    • Teva Pharmaceutical Industries Ltd
図表

List of Figures

  • Figure 1: Global: Hormonal Contraceptive Market: Major Drivers and Challenges
  • Figure 2: Global: Hormonal Contraceptive Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Hormonal Contraceptive Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Hormonal Contraceptive Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Hormonal Contraceptive Market: Breakup by Hormone (in %), 2022
  • Figure 6: Global: Hormonal Contraceptive Market: Breakup by Age Group (in %), 2022
  • Figure 7: Global: Hormonal Contraceptive Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Hormonal Contraceptive Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Hormonal Contraceptive (Injectable Birth Control) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Hormonal Contraceptive (Injectable Birth Control) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Hormonal Contraceptive (Vaginal Rings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Hormonal Contraceptive (Vaginal Rings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Hormonal Contraceptive (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Hormonal Contraceptive (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Hormonal Contraceptive (15-24 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Hormonal Contraceptive (15-24 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Hormonal Contraceptive (25-34 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Hormonal Contraceptive (25-34 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Hormonal Contraceptive (35-44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Hormonal Contraceptive (35-44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Hormonal Contraceptive (Above 44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Hormonal Contraceptive (Above 44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Hormonal Contraceptive (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Hormonal Contraceptive (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Hormonal Contraceptive (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Hormonal Contraceptive (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Hormonal Contraceptive (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Hormonal Contraceptive (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Hormonal Contraceptive Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Hormonal Contraceptive Industry: SWOT Analysis
  • Figure 89: Global: Hormonal Contraceptive Industry: Value Chain Analysis
  • Figure 90: Global: Hormonal Contraceptive Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hormonal Contraceptive Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Hormonal Contraceptive Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Hormonal Contraceptive Market Forecast: Breakup by Hormone (in Million US$), 2023-2028
  • Table 4: Global: Hormonal Contraceptive Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
  • Table 5: Global: Hormonal Contraceptive Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Hormonal Contraceptive Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Hormonal Contraceptive Market: Competitive Structure
  • Table 8: Global: Hormonal Contraceptive Market: Key Players
目次
Product Code: SR112023A4403

Abstract

The global hormonal contraceptive market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.9 Billion by 2028, exhibiting a growth rate (CAGR) of 4.19% during 2022-2028.

Hormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.

Hormonal Contraceptive Market Trends:

The global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, hormone, age group and end user.

Breakup by Product:

Oral Contraceptive Pills

Intrauterine Device (IUD)

Injectable Birth Control

Vaginal Rings

Others

Breakup by Hormone:

Progestin-only Contraceptive

Combined Hormonal Contraceptive

Breakup by Age Group:

15-24 Years

25-34 Years

35-44 Years

Above 44 Years

Breakup by End User:

Hospitals and Clinics

Homecare

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global hormonal contraceptive market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hormonal contraceptive market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the hormone?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hormonal contraceptive market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormonal Contraceptive Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intrauterine Device (IUD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Injectable Birth Control
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Vaginal Rings
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Hormone

  • 7.1 Progestin-only Contraceptive
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Combined Hormonal Contraceptive
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 15-24 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 25-34 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 35-44 Years
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Above 44 Years
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Homecare
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Afaxys Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agile Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Allergan Inc. (AbbVie Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Bayer AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Cipla Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Piramal Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Teva Pharmaceutical Industries Ltd
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis